Sagittarius IP is a firm of Chartered and European Patent Attorneys who specialise in chemical, pharmaceutical and biotechnology subject matter. We provide the following services: drafting, filing and prosecution of patent applications and representation before the UK and European Patent Offices, including oppositions and other contentious work; filing of international patent applications (PCT) and control of worldwide patent prosecution; advice on IP strategy; freedom to operate investigation; IP due diligence; and IP education. Sagittarius IP was set up in 2002 and opened a Cambridge office in 2009.
No data available
Scantox is a leading preclinical GLP-accredited CRO, specialized in providing services within the drug development process. The business is divided into the 4 divisions: Discovery, Genetic Toxicology, Regulatory Toxicology and Pharmaceutical Development & Analytical.
Based on decades of experience, Scantox is a trusted partner for CRO services for the pharmaceutical and medical devices industries. Services enable clients to progress their drug or device development based on solid data to the highest technical and scientific standards.
Scantox Group is headquartered in Denmark, with subsidiaries in UK, Austria, Denmark and Sweden (Lund, Gothenburg and Solna). The Scantox team is passionate about the common vision to improve the health of people, and all processes are rooted in dedication and guided by a strong sense of purpose. Founded in 1977, Scantox is today owned by the Nordic based investment company Impilo. Certified as a 2023 Great Place To Work™.
Based on decades of experience, Scantox is a trusted partner for CRO services for the pharmaceutical and medical devices industries. Services enable clients to progress their drug or device development based on solid data to the highest technical and scientific standards.
Scantox Group is headquartered in Denmark, with subsidiaries in UK, Austria, Denmark and Sweden (Lund, Gothenburg and Solna). The Scantox team is passionate about the common vision to improve the health of people, and all processes are rooted in dedication and guided by a strong sense of purpose. Founded in 1977, Scantox is today owned by the Nordic based investment company Impilo. Certified as a 2023 Great Place To Work™.
Scendea is an international product development & regulatory consulting Group, delivering market-leading scientific expertise & regulatory solutions, to advance healthcare innovation worldwide. We are committed problem solvers, redefining the meaning of customer service, with a focus on reducing time-to-market and minimising development costs. Our expert team, based in the UK, the Netherlands, Australia, and the US, provide strategic and operational support in the fields of Non-Clinical, CMC, Clinical, and Regulatory to successfully guide products from early development to marketing approval.
Further information on our services can be seen on our website https://www.Scendea.com/services
Further information on our services can be seen on our website https://www.Scendea.com/services
No data available
No data available
No data available
Shionogi's policy is to strive constantly to provide medicine of the best possible kind essential for the protection of the health of the people. Our mission, based on this policy, is to deliver pharmaceuticals that offer the greatest possible level of satisfaction to patients, their families, and healthcare providers and that improve quality of life for patients and their families. To achieve the above goal, we are constantly engaged in research, development, manufacturing, and marketing activities, with a primary focus on prescription drugs.
Simbec Research has over 35 years' experience in clinical drug development, specialising in healthy and patient volunteer studies. Simbec's Phase I-IIa services include: first into man phase I studies, single and multi-dose tolerability; proof of concept phase IIa studies; drug-drug interaction studies; bioavailability/bioequivalence studies; mass balance/ADME/microdosing; genotyping/phenotyping; bioanalytical services (including assay development); central laboratory services; and QTc studies. Support services include: regulatory, protocol and report writing, medical writing, project management, and data management and statistics pharmacokinetics. Niche services include: ophthalmic research, gamma scintigraphy, dermatology and respiratory.
No data available